Tularemia, a rare but serious disease caused by the bacterium Francisella tularensis, poses significant treatment challenges due to its ability to evade the immune system.
Symptoms of tularemia can include fever, swollen lymph nodes, and pneumonia, complicating diagnosis and management.
The identification of specific proteins within the bacterium could lead to the development of new treatment strategies, offering hope for better patient outcomes.